The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Benchmark:
BSE HEALTHCARE
Fund Manager:
Sanjay Chawla
Aditya Birla Sun Life Pharma and Healthcare fund | 12.50(1Y) | 24.07(3Y) |
DSP Healthcare Fund | 17.95(1Y) | 27.30(3Y) |
Health and wellness comprises of pharma, healthcare and many allied services and products. With rising affluence, bigger opportunities should arise.
Fund House AAUM:
Rs. 4554083.03 lakhs (as on 31st March, 2025)
Fund Manager:
Experience of above 33 years
Well it is not a new sector. There could be tweaks but unlikely to be substantial. I would sit it out.